Dr. Emma Guttman discussed JAK Inhibitors and Skin Biomarkers at the EAACI World Congress 2024

Exciting times in JAK inhibitors and skin biomarkers and atopic dermatitis. Dr. Emma Guttman gave a presentation to the The European Academy of Allergy and Clinical Immunology (EAACI) World Congress, May 2024, on how the therapeutic drought is finally ending, especially in the oral space. Skin and blood profiling helped formulate pathogenic hypotheses. Success and failures helped develop new treatments. Inflammation is more than skin deep: AD emerged as a systemic disease and more were explored.